Type 2 Diabetes Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- The trial is looking for 120 participants in total — 60 Chinese Americans and 60 Vietnamese Americans.
- Adults aged 18 or older who live independently in the community.
- People who have been diagnosed with type 2 diabetes.
- People whose HbA1c (a blood sugar measure taken over roughly 3 months) is above 7.0%.
- People who identify as first- or second-generation Chinese or Vietnamese immigrants.
- People who are able to communicate in English, Chinese (Mandarin or Cantonese), or Vietnamese.
- People who own a smartphone, iPad, tablet, or Apple Watch.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who are taking certain diabetes medications — such as insulin or sulfonylureas — that can cause low blood sugar and require close monitoring.
- People who have taken medications that can make weight loss harder (for example, prednisone) at any point in the last 3 months.
- People who are currently pregnant, breastfeeding, or planning to become pregnant within the next 6 months.
- People who have serious physical health conditions such as severe nerve damage, heart disease, severe lung disease, severe joint disease, or who have had a stroke — or who have serious mental health conditions such as schizophrenia, bipolar disorder, severe depression, or active substance use problems.
- People who have conditions that affect what they can eat, such as severe stomach-emptying problems, ulcers, or significant food allergies.
- People who are currently receiving cancer treatment.
- People who have significant kidney disease (confirm with trial site for specific kidney function levels).
- People who are taking certain psychiatric medications known to raise blood sugar levels (such as some antipsychotic medicines).
- People who have previously used or are currently using a continuous glucose monitor (CGM) device — such as Dexcom or FreeStyle Libre — and plan to keep using one over the next 6 months.
- People who are currently taking part in another type 2 diabetes treatment study.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Yaguang Zheng, PhD, RN, NYU Langone Health
Phone: 212-998-5170
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Recruitment Rate; Retention Rate; Glycated Hemoglobin (A1c) Level - Baseline; Glycated Hemoglobin (A1c) Level - Week 12; Glycated Hemoglobin (A1c) Level - Week 24; Time in Range (TIR) - Baseline; Time in Range (TIR) - Week 12; Time in Range (TIR) - Week 24
Can't join this trial?
Data last synced from ClinicalTrials.gov: 29 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.